PubRank

Christiana Winkler

Author PubWeight™ 27.20‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Monitoring tryptophan metabolism in chronic immune activation. Clin Chim Acta 2005 2.29
2 Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. Clin Cancer Res 2006 2.26
3 Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells. Blood 2004 1.34
4 Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients. Dermatology 2007 1.23
5 Tryptophan degradation increases with stage in patients with rheumatoid arthritis. Clin Rheumatol 2005 1.17
6 Crucial role of interferon-gamma and stimulated macrophages in cardiovascular disease. Curr Vasc Pharmacol 2006 1.09
7 Neopterin in HIV-1 infection. Mol Immunol 2005 1.08
8 Bariatric surgery cannot prevent tryptophan depletion due to chronic immune activation in morbidly obese patients. Obes Surg 2006 0.99
9 Antitumoral activity of interferon-gamma involved in impaired immune function in cancer patients. Curr Drug Metab 2006 0.99
10 Diminished quality of life in patients with cancer correlates with tryptophan degradation. J Cancer Res Clin Oncol 2007 0.95
11 Resveratrol suppresses interferon-gamma-induced biochemical pathways in human peripheral blood mononuclear cells in vitro. Immunol Lett 2005 0.94
12 Tryptophan degradation in patients with gynecological cancer correlates with immune activation. Cancer Lett 2004 0.93
13 CTLA4Ig promotes the induction of hematopoietic chimerism and tolerance independently of Indoleamine-2,3-dioxygenase. Transplantation 2007 0.90
14 Cognitive deterioration in Alzheimer's disease is accompanied by increase of plasma neopterin. J Psychiatr Res 2006 0.88
15 Hyperhomocysteinaemia and immune activation in patients with cancer. Clin Chem Lab Med 2007 0.85
16 Effects of adalimumab therapy on disease activity and interferon-γ-mediated biochemical pathways in patients with rheumatoid arthritis. Autoimmunity 2011 0.84
17 Antioxidants may increase the probability of developing allergic diseases and asthma. Med Hypotheses 2005 0.83
18 Interferon-gamma-mediated pathways and in vitro PBMC proliferation in HIV-infected patients. Biol Chem 2009 0.82
19 Atorvastatin suppresses homocysteine formation in stimulated human peripheral blood mononuclear cells. Clin Chem Lab Med 2005 0.82
20 Hyperhomocysteinemia and immune activation. Clin Chem Lab Med 2003 0.82
21 Anti-inflammatory compound resveratrol suppresses homocysteine formation in stimulated human peripheral blood mononuclear cells in vitro. Clin Chem Lab Med 2005 0.81
22 Monocyte-mediated T-cell suppression and augmented monocyte tryptophan catabolism after human hematopoietic stem-cell transplantation. Blood 2005 0.81
23 Homocysteine and serum markers of immune activation in primary dystonia. Mov Disord 2005 0.79
24 Non-peptidic delta-opioid receptor antagonists suppress mitogen-induced tryptophan degradation in peripheral blood mononuclear cells in vitro. Immunol Lett 2008 0.78
25 Immune activation in autism. Pediatr Neurol 2006 0.77
26 Method for urinary neopterin measurements by HPLC. J Biochem Biophys Methods 2005 0.75
27 In vitro testing for antiinflammatory properties of compounds. Clin Chem 2006 0.75
28 Relationship between homocysteine and neopterin concentrations in patients with gynecological cancer. Cancer Lett 2005 0.75